Now showing items 1-2 of 2
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
(BioMed Central, 2017) info:eu-repo/semantics/article,
Background: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and metastasis. Its role in cancer is controversial because it has been described as being upregulated in ...
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
(Impact Journals, 2017) info:eu-repo/semantics/article,
The CHL1 gene encodes a cell-adhesion molecule proposed as being a putative tumour-suppressor gene in breast cancer (BC). However, neither the underlying molecular mechanisms nor the clinical value of CHL1 downregulation ...